Literature DB >> 15725387

Macrophages at intermediate stage of maturation produce high levels of IL-12 p40 upon stimulation with Leishmania.

Milton A P Oliveira1, Carlos E Tadokoro, Glória M C A Lima, Tainá Mosca, Leda Q Vieira, Pieter J M Leenen, Ises A Abrahamsohn.   

Abstract

IL-12 is one of the main cytokines driving the immune response to a resistant phenotype in leishmaniasis and in several other diseases involving intracellular microbes. In this study, we investigated IL-12 production by mononuclear phagocytes at several developmental stages when stimulated with Leishmania major, L. amazonensis or L. chagasi. Bone marrow cells were cultured for 4-6 days in vitro in the presence of M-CSF, GM-CSF or IL-3. After density separation, only cells banding at the 40-50% Percoll interface, but not those at 20-40% or 50-80% interfaces, produced large amounts of IL-12 p40 when stimulated with LPS or live Leishmania promastigotes. However, only low levels of IL-12 p70 were produced under these conditions. The high IL-12 p40-producing cells could be similarly derived from mouse strains with different susceptibility to Leishmania. Quantitative analysis of monocyte/macrophage lineage marker expression, in combination with positive and negative selection, led to the conclusion that the high IL-12 p40-producing cells are macrophages at an intermediate stage of maturation between immature and fully differentiated cells, expressing ER-HR3 but only low levels of the mature markers, scavenger receptor and CD11b/Mac-1. They do not express any of the precursor markers CD31/ER-MP12, Ly-6C/ER-MP20 or ER-MP58. Because recruitment of monocytes to an infection site and its draining lymph node is a general phenomenon, the notion that, developing from these monocytes, a population of mononuclear phagocytes at an intermediate maturation stage has the capacity to synthesize large amounts of IL-12 p40 has significant bearing on our understanding of immune regulation in leishmaniasis and also in infections by other pathogens.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15725387     DOI: 10.1016/j.micinf.2004.10.013

Source DB:  PubMed          Journal:  Microbes Infect        ISSN: 1286-4579            Impact factor:   2.700


  2 in total

1.  UCP2 deficiency helps to restrict the pathogenesis of experimental cutaneous and visceral leishmaniosis in mice.

Authors:  Javier Carrión; M Angeles Abengozar; María Fernández-Reyes; Carlos Sánchez-Martín; Eduardo Rial; Gustavo Domínguez-Bernal; M Mar González-Barroso
Journal:  PLoS Negl Trop Dis       Date:  2013-02-21

2.  Impact of reactive oxygen species (ROS) on the control of parasite loads and inflammation in Leishmania amazonensis infection.

Authors:  Eric Henrique Roma; Juan Pereira Macedo; Grazielle Ribeiro Goes; Juliana Lauar Gonçalves; Waldionê de Castro; Daniel Cisalpino; Leda Quercia Vieira
Journal:  Parasit Vectors       Date:  2016-04-07       Impact factor: 3.876

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.